Steve Wring

The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation

Emily L. Larkin, Christopher Hager, Jyotsna Chandra et al. · Antimicrobial Agents and Chemotherapy · 2017 · 393 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Midazolam Exhibits Characteristics of a Highly Permeable P-Glycoprotein Substrate

Sanna Tolle‐Sander, Jarkko Rautio, Steve Wring et al. · Pharmaceutical Research · 2003 · 80 citations

Pharmacy, Pharmacokinetics, Pharmacology +9

A Novel 1,3-Beta- <scp>d</scp> -Glucan Inhibitor, Ibrexafungerp (Formerly SCY-078), Shows Potent Activity in the Lower pH Environment of Vulvovaginitis

Emily L. Larkin, L. Long, N. Isham et al. · Antimicrobial Agents and Chemotherapy · 2019 · 49 citations · Full text

Medicine, Infectious Diseases, Pharmacology +14

Development of a Novel Formulation That Improves Preclinical Bioavailability of Tenofovir Disoproxil Fumarate

Melynda Watkins, Steve Wring, Ryan Randolph et al. · Journal of Pharmaceutical Sciences · 2016 · 21 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

Safety and efficacy of rodatristat ethyl for the treatment of pulmonary arterial hypertension (ELEVATE-2): a dose-ranging, randomised, multicentre, phase 2b trial

Olivier Sitbon, Andris Skride, Jeremy Feldman et al. · The Lancet Respiratory Medicine · 2024 · 17 citations

Medicine, Cardiology, Pharmacology +13